Lab Information

Momar Ndao (PhD)

Centre for Translational Biology
Department of Medicine (McGill)

Research Profile

 Fundamental: 75%
 Clinical: 25%
 Epidemiology: 0%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Infectious diseases • parastic infections • host-parasite interactions

Research Interests

My research focuses on: bringing cutting edge science to diagnose infectious diseases, studying host-parasite interactions, screening drugs to be used as therapies for infectious diseases, developing vaccines to prevent parasitic diseases, and applying proteomic technology to discover biomarkers for infectious diseases. Increased awareness of parasitic infections has led to newly recognized parasites, emerging pathogens, and bioterrorism considerations. Therefore, the fields of diagnostic medical parasitology treatment and vaccines are undergoing dramatic change.

Team Members

Name Position

Latest Publications

  1. Perera, D. J., Hassan, A. S., Liu, S. S., Elahi, S. M., Gadoury, C., Weeratna, R. D., Gilbert, R. & Ndao, M. (2022). A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice. EBioMedicine, vol. 80, p. 104036.
  2. Morsi, H., Golizeh, M., Brosseau, N., Janati, A. I., Emami, E., Ndao, M. & Tran, S. D. (2022). Corrigendum to "Detection of Fusobacterium nucleatum subspecies in the saliva of precolorectal cancer patients, using tandem mass spectrometry" [AOB 134C (2022) 105337]. Archives of oral biology, vol. 137, p. 105398.
  3. Morsi, H., Golizeh, M., Brosseau, N., Janati, A. I., Emami, E., Ndao, M. & Tran, S. D. (2021). Detection of Fusobacterium nucleatum subspecies in the saliva of pre-colorectal cancer patients, using tandem mass spectrometry. Archives of oral biology, vol. 134, p. 105337.
  4. Mouhoub, E., Domenech, P., Ndao, M. & Reed, M. B. (2021). The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview. Frontiers in microbiology, vol. 12, p. 757858.
  5. Yansouni, C. P., Papenburg, J., Cheng, M. P., Corsini, R., Caya, C., Vasquez Camargo, F., Harrison, L. B., Zaharatos, G., Büscher, P., Faye, B., Ndiaye, M., Matlashewski, G. & Ndao, M. (2021). Specificity of SARS-CoV-2 antibody-detection assays against S and N protein among pre-COVID-19 sera from patients with protozoan and helminth parasitic infections. Journal of clinical microbiology, p. JCM0171721.
  6. Sonzogni-Desautels, K. & Ndao, M. (2021). Will Auranofin Become a Golden New Treatment Against COVID-19?. Frontiers in immunology, vol. 12, p. 683694.
  7. Perera, D. J. & Ndao, M. (2021). Promising Technologies in the Field of Helminth Vaccines. Frontiers in immunology, vol. 12, p. 711650.
  8. Drews, S. J., Van Caeseele, P., Bullard, J., Lindsay, L. R., Gaziano, T., Zeller, M. P., Lane, D., Ndao, M., Allen, V. G., Boggild, A. K., O'Brien, S. F., Marko, D., Musuka, C., Almiski, M. & Bigham, M. (2022). Babesia microti in a Canadian blood donor and lookback in a red blood cell recipient. Vox sanguinis, vol. 117, p. 438-441.
  9. Hassan, A. S., Perera, D. J., Ward, B. J. & Ndao, M. (2021). Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection. Vaccine, vol. 39, p. 5580-5588.
  10. Ducrocq, J., Ndao, M., Yansouni, C. P., Proulx, J.-F., Mondor, M., Hamel, D., Lévesque, B., De Serres, G. & Talbot, D. (2021). Epidemiology associated with the exposure to Toxoplasma gondii in Nunavik's Inuit population using the 2017 Qanuilirpitaa cross-sectional health survey. Zoonoses and public health, vol. 68, p. 803-814.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile